Human Plasma Components for Coagulation Disorders

🩸 Human Plasma Components for Coagulation Disorders (Therapeutic/Prophylactic/Diagnostic)

🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Clearance Strategy
📌 I. Product Definition and Classification: Do You Understand "Human Blood Products"?

Human plasma, specifically those prepared for therapeutic, prophylactic, or diagnostic uses (such as coagulation factors, albumin, or immunoglobulins derived from human blood), is strictly regulated under international trade laws. In international trade, it is categorized based on its modification status and specific biological origin.

1. Human Blood Plasma (Specific Fraction): Plasma specifically processed and intended for therapeutic use, such as for treating coagulation disorders (e.g., Hemophilia A/B, Von Willebrand disease). This falls under the specific sub-category of "Human blood plasma."
2. Other Blood Fractions: Any other animal or human blood fractions not specifically classified as "Human blood plasma" but still derived from blood for medical use. This is a general/residual category under "Antisera and other blood fractions."

⚠️ Key Distinction Point:
- If the product is explicitly identified as "Human Blood Plasma" prepared for medical use (therapeutic/diagnostic/prophylactic) →归入 3002.12.00.10
- If the product is a blood fraction but not explicitly "human plasma" (e.g., other animal blood fractions, or unspecified human fractions) → 归入 3002.12.00.90

📦 II. HS Code Classification Details (2026 Latest Tariff Authority Comparison)

🔍 Key Reminder:
- All human blood products prepared for medical use fall under Chapter 30 (Pharmaceutical Products), specifically heading 3002.
- The distinction between .10 and .90 is critical: .10 is for Human Blood Plasma; .90 is the residual category for other blood fractions/antisera.
- Vaccines, toxins, and cell cultures are also in Chapter 30 but fall under different subheadings (not shown here). This guide focuses on blood fractions/plasma.

💰 III. 2026 Latest Tariff Rate Details (Including Additional Taxes, Policy Add-ons)

✅ Applicable Country: United States (US)
✅ Origin: China (CN)
✅ Effective Time: 2025年11月10日起 (Including subsequent imports)
✅ Base Tariff: 0.0% for both codes

🎯 1. 3002.12.00.10 —— Human Blood Plasma

📌 Explanation:
- Human plasma and blood fractions are listed with a 0% base tariff.
- Unlike electronics or steel, medical biological products (including human plasma) currently do not face additional Section 301 or IEEPA tariffs in the US.
- Total Tax Rate is 0%, making this a low-tariff category for customs purposes.

🎯 2. 3002.12.00.90 —— Other Blood Fractions

📌 Note:
- Same tax treatment as 3002.12.00.10.
- Whether it is human plasma or other blood fractions, the tariff burden is minimal (0%).
- The primary challenge for this category is regulatory compliance (FDA), not tariff cost.

🛠️ IV. Customs Clearance Practical Advice (Avoid Pitfalls)

✅ 1. Required Documentation Checklist (All are Mandatory)

✅ 2. Declaration Tips (Key Rules)

🔥 “准确归类，FDA先行，温度达标，清关无忧！”

✅ 3. Special Situation Handling

🌍 V. Global Market Comparison (2026 Latest)

📌 Conclusion:
- Tariff is 0% globally for most major markets for blood plasma/fractions.
- Regulatory compliance (FDA, EMA, NMPA) is the real barrier, not tariff.
- Cold chain integrity is critical to avoid rejection.

📌 VI. Common Errors & Pitfalls (Lessons Learned)

❌ Error 1: Misdeclaring "Human Plasma" as "Other Biologicals" (3002.12.00.90) when it is explicitly human plasma.
👉 Consequence: Potential customs penalty or audit.

❌ Error 2: Failing to file FDA Prior Notice before arrival.
👉 Consequence: Detention, Refusal of Entry, or Destruction of goods.

❌ Error 3: Inadequate cold chain documentation.
👉 Consequence: Rejection due to suspected degradation of biological activity.

❌ Error 4: Using vague descriptions like "Blood Products" without specifying Human or Animal origin.
👉 Consequence: Customs delays for classification verification.

✅ Correct Practice:

"Human Blood Plasma, Cryoprecipitate-AH, for Therapeutic Use, Frozen, FDA Regulated, Batch No. XYZ, Temperature -20°C ± 5°C"

🎯 VII. Conclusion: Professional Declaration, Smooth Clearance, Cost Efficiency!

🎯 Remember the Mantra:

🔹 "FDA先行，温度达标，归类准确，关税为零！"
🔹 "HS Code定方向，FDA审批定生死，温度控制保质量，关税虽零风险高！"

📌 Tips:
- If your plasma is originating from non-China countries, you may still face FDA scrutiny.
- Ensure viral inactivation steps are documented.
- Consider pre-clearance consultation with FDA and customs brokers.

📣 Immediate Action:

📞 Contact FDA-licensed customs brokers + Provide Product Specifications + File FDA Prior Notice
🚀 Let your plasma products clear customs smoothly, efficiently, and safely!

✨ Professional Clearance, Starting with Accurate Classification!
💼 Your Every Penny is Worth Precision Calculation!